Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement

被引：55
|
作者：
Saito, K [1 ]
Nawata, M [1 ]
Nakayamada, S [1 ]
Tokunaga, M [1 ]
Tsukada, J [1 ]
Tanaka, Y [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
来源：
LUPUS | 2003年 / 12卷 / 10期
关键词：
D O I：
10.1191/0961203303lu450xx
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：798 / 800
页数：3
相关论文
共 50 条
  • [41] Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    Herrmann, G
    Engert, A
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 602 - 603
  • [42] Anti-CD20 chimeric monoclonal antibody (Rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris: Implications for its use in other autoimmune antibody mediated diseases
    Salopek, T
    Logsetty, S
    Tredget, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 542 - 542
  • [43] Mucocutaneous Lichen Planus With Esophageal Involvement Successful Treatment With an Anti-CD20 Monoclonal Antibody
    Parmentier, Laurent
    Bron, Blaise-Alain
    Prins, Christa
    Samson, Jacky
    Masouye, Isabelle
    Borradori, Luca
    ARCHIVES OF DERMATOLOGY, 2008, 144 (11) : 1427 - 1430
  • [44] Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab
    Ramadan, K. M.
    Eswedi, H. A.
    El-Agnaf, M. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) : 1072 - 1074
  • [45] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
    Brændstrup, P
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) : 275 - 280
  • [46] Successful treatment of Lymphoid granulomatosis with anti-CD20 monoclonal antibody rituximab rationale and a case report
    Jordan, Karin
    Grothe, Wilfried
    Grothey, Axel
    Kegal, Thomas
    Schmoll, Hans J.
    ANNALS OF ONCOLOGY, 2004, 15 : 158 - 158
  • [47] Anti-cd20 monoclonal antibody treatment (rituximab) in acute lymphoblastic leukemia
    Jándula, BM
    Nomdedeu, J
    Marín, P
    Muñoz, L
    Vivancos, P
    BONE MARROW TRANSPLANTATION, 2001, 27 : S92 - S92
  • [48] Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
    Cooper, HL
    Healy, E
    Theaker, JM
    Friedmann, PS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (04) : 366 - 368
  • [49] Longterm clinical and immunological effects of Anti-CD20 treatment in patients with refractory systemic lupus erythematosus
    Lindholm, Catharina
    Boerjesson-Asp, Katharina
    Zendjanchi, Kiandokht
    Sundqvist, Anna-Carin
    Tarkowski, Andrej
    Bokarewa, Maria
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 826 - 833
  • [50] Treatment of Cutaneous Lymphoid Hyperplasia with the Monoclonal Anti-CD20 Antibody Rituximab
    Martin, Stephanie J.
    Duvic, Madeleine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03) : 286 - 288
12345